Key result
IHD linked to ~11-fold higher dyslipidemia risk alongside hypertension and obesity.
Cross-Sectional (n=1,132)
Odds Ratio: 11.21 (95% CI 6.16–20.43)
Dyslipidemia affects 13.5% of adults in the Kurdistan Region of Iraq and is strongly associated with low education, obesity, hypertension, and ischemic heart disease.
Cardiovascular diseases (CVD) remain the leading cause of global mortality, with dyslipidemia being a major modifiable risk factor. Dyslipidemia remains inadequately studied in developing countries like Iraq, so this study aims to assess the prevalence and determinants of dyslipidemia among residents of the Kurdistan Region of Iraq. This cross-sectional study was conducted between January and April 2025 and included 1132 participants aged ≥ 18 years. Dyslipidemia was defined based on prior confirmed diagnosis with documented laboratory, chronic disease registry identification card or specialist physician report. The overall prevalence of dyslipidemia was 13.5%, lower than neighboring regions, with higher prevalence in men (15.8%) compared to women (9.9%). Significant determinants of dyslipidemia in multivariable logistics regression included low education (OR 3.197, 95% CI: 2.257–4.527), obesity (4.039, 2.464–6.619), hypertension (6.301, 4.205–9.44), and ischemic heart disease (11.21, 6.16–20.43). These findings underscore the need for public health initiatives focused on promoting healthy lifestyles, particularly in at-risk populations, to reduce the burden of dyslipidemia and prevent cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2026) conducted a cross-sectional in Dyslipidemia (n=1,132). Ischemic heart disease vs. No ischemic heart disease was evaluated on Dyslipidemia (OR 11.21, 95% CI 6.16-20.43). Ischemic heart disease (OR 11.21; 95% CI 6.16-20.43), hypertension, obesity, and low education were identified as significant determinants of dyslipidemia, which had an overall prevalence of 13.5%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: